Replies to post #378866 on Elite Pharmaceuticals Inc (ELTP)

[IB_]

I agree, I believe a successful marketing arm should be established and revenues seem secure and going in the right direction first ........ but I do not believe NasRat/The useless Board will ever issue a share repurchase program and IF they did, I doubt they would move toward implementing it, aggressively !!!!!!!!!!!!!!!!!!!!!!!

IB_

[The ELTP King]

The market is not forward looking AT ALL.

In fact, it's the EXACT opposite.

In 2021, Lannett RENEWED it's Agreement for 2 MORE YEARS for 3 different products.

What did the "market" do?..................ANSWER: TANK Elite's stock for the next year.

WHY did Elite's stock tank after this great news?

ANSWER: Because the market HATES revenues, profits, and guaranteed income.

MORE MONEY = LOWER SHARE PRICE

Evidence:

1. On October 18, 2021, Elite renewed its License, Supply, and Distribution Agreement with Lannett to market Adderall XR and Adderall IR. The First Renewal Term shall be from March 22, 2022 until March 5, 2024.

2. On October 18, 2021, Elite renewed its License, Supply and Distribution Agreement with Lannett to market Elite’s generic Dantrolene Capsules. The First Renewal Term shall be fromApril 9, 2022 until April 8, 2024.

Only if excess cash is used and doesn’t risk company’s future potential. Market is forward looking.